CDC42 and c-CBL are the critical components involved in the regulation of EGFR protein levels, and restoring proper EGFR degradation by disrupting the regulation of c-CBL by CDC42 can effectively reduce the proliferation and migration of breast cancer cells (Hirsch et al., 2006). Here, EGFR is linked to breast cancer.